BBLN Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-15 | Johnson Mairi | director | 1,958 | M-Exempt | D | 130 | 0.00 | 0.00 |
| 2023-03-15 | Johnson Mairi | director | 147,272 | F-InKind | D | 12,728 | 6.86 | 87,314.08 |
| 2023-03-15 | Johnson Mairi | director | 342 | F-InKind | D | 291 | 6.86 | 1,996.26 |
| 2023-03-15 | Johnson Mairi | director | 633 | M-Exempt | A | 130 | 0.00 | 0.00 |
| 2023-03-15 | Parsadoust Ali | director, 10 percent owner, officer: Chief Executive Officer | 1,958 | M-Exempt | D | 130 | 0.00 | 0.00 |
| 2023-03-15 | Parsadoust Ali | director, 10 percent owner, officer: Chief Executive Officer | 342 | F-InKind | D | 291 | 6.86 | 1,996.26 |
| 2023-03-15 | Parsadoust Ali | director, 10 percent owner, officer: Chief Executive Officer | 633 | M-Exempt | A | 130 | 0.00 | 0.00 |
| 2023-03-15 | Parsadoust Ali | director, 10 percent owner, officer: Chief Executive Officer | 147,272 | F-InKind | D | 12,728 | 6.86 | 87,314.08 |
| 2023-03-15 | Sanghavi Darshak | officer: Chief Medical Officer | 40,394 | S-Sale | D | 3,202 | 7.21 | 23,086.42 |
| 2023-03-14 | WARREN DAVID P | director | 161 | F-InKind | D | 132 | 7.32 | 966.24 |
| 2023-03-14 | Humphreys David James | officer: Chief Financial Officer | 2,280 | M-Exempt | D | 31 | 8.46 | 262.26 |
| 2023-03-14 | Humphreys David James | officer: Chief Financial Officer | 22,896 | F-InKind | D | 15 | 8.46 | 126.90 |
| 2023-03-14 | Humphreys David James | officer: Chief Financial Officer | 22,911 | M-Exempt | A | 31 | 0.00 | 0.00 |
| 2023-03-14 | Sanghavi Darshak | officer: Chief Medical Officer | 43,596 | S-Sale | D | 3,743 | 7.66 | 28,671.38 |
| 2023-03-13 | Ferrand Paul-Henri | officer: Chief Operating Officer | 141,413 | F-InKind | D | 20,095 | 8.46 | 170,003.70 |
| 2023-03-13 | Humphreys David James | officer: Chief Financial Officer | 2,311 | M-Exempt | D | 177 | 8.46 | 1,497.42 |
| 2023-03-13 | Humphreys David James | officer: Chief Financial Officer | 22,880 | F-InKind | D | 84 | 8.46 | 710.64 |
| 2023-03-13 | Humphreys David James | officer: Chief Financial Officer | 22,964 | M-Exempt | A | 177 | 0.00 | 0.00 |
| 2023-03-13 | Sanghavi Darshak | officer: Chief Medical Officer | 5,659 | M-Exempt | D | 628 | 0.00 | 0.00 |
| 2023-03-13 | Sanghavi Darshak | officer: Chief Medical Officer | 47,339 | S-Sale | D | 2,640 | 8.50 | 22,440.00 |
| 2023-03-13 | Sanghavi Darshak | officer: Chief Medical Officer | 49,979 | F-InKind | D | 218 | 8.46 | 1,844.28 |
| 2023-03-13 | Sanghavi Darshak | officer: Chief Medical Officer | 50,197 | F-InKind | D | 3,465 | 8.46 | 29,313.90 |
| 2023-03-13 | Sanghavi Darshak | officer: Chief Medical Officer | 53,662 | M-Exempt | A | 628 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.